Chronic hypopituitarism was noted in 44% of US veterans with mild traumatic brain injury.
Phthalate exposure effect explained half of the attention deficit in children treated in the ICU.
The vaccine also restored normal glucose tolerance.
The efficacy and safety of abaloparatide was studied in a randomized, double-blind, multicenter trial evaluating fracture prevention in ambulatory, postmenopausal women with osteoporosis.
Andrew Ahmann, MD, discusses the Endocrine Society's new updates on diabetes technology.
Megan Haymart, MD, discusses new ATA guidelines for radioactive iodine treatment in thyroid cancer.
Investigational drug improved vaginal cells and vaginal pH at all dose levels.
Jonathan LoPresti, MD, PhD, discusses the challenges of taking thyroglobulin measurements at ENDO 2016.
Rocio Pereira, MD, discusses the association between diabetes and infectious diseases in developing countries.
People who lived in the warmest homes had a 2.8-cm larger waist circumference than those in the coolest homes
Douglas Ross, MD, discusses changes in ATA guidelines regarding the treatment of hyperthyroidism.
Verbal memory and cognitive flexibility improved after 6 months of estrogen replacement therapy.
The temporary 1-year intestinal bypass device with liraglutide boosts weight loss and improves diabetes control.
Michael McClung, MD, discusses his presentation about new drugs for the treatment of osteoporosis.
Elizabeth Pearce, MD, MSc, and Erik Alexander, MD, elaborate on the revised ATA guidelines about thyroid care in pregnancy.
Sleeve with ileal transposition surgery resulted in better glycemic control in mildly obese patients with diabetes.
The "Paleolithic-type" diet may have long-term health benefits related to obesity.
Infants in the 85th percentile for BMI are at increased risk for obesity by age 6.
High doses of folic acid appeared to mitigate the effects of bone loss.
Bone mineral density was 3.7% to 5.3% lower at all sites.
The risk was greater even for people with low-normal thyroid function.
Clinicians should consider the benefits and risks of hormone therapy when treating this patient population.
The use of these products for thyroid disorders or menopause is often unnecessary.
Cryopresrvation, ovarian transplantion, and ovarian stimulation represent significant advances in the study of fertility preservation.
Many people are "cyclers" who consistently gain and lose weight.
Participants assigned to a whey protein lost more weight at 3 months than those assigned to other proteins or starch.
Researchers discovered for the first time that glucagon-like peptide 1 receptors are in the human brain.
Risk for asthma was increased by 34% in women with polycystic ovary syndrome.
Serum anti-Müllerian hormone levels may help identify women who may lose bone mass the fastest.
A 3D-printed ovarian prosthesis restored the female hormone cycle and supported natural ovulation in mice.
Endocrinology Advisor Articles
- Predictors of Success for Insulin-to-Liraglutide Switch for Type 2 Diabetes
- Efficacy and Safety of Alirocumab in Diabetes Mellitus
- Safety of DPP-IV Inhibitor, Cardiovascular Events After ACS in Type 2 Diabetes
- Transgender Youth Not Willing to Delay Hormone Therapy for Fertility Preservation
- Pre-Pregnancy Programs May Improve Outcomes in Women With Type 2 Diabetes
- Diabetes Treatments
- Metformin May Decrease Colorectal Cancer Risk Among Males With Diabetes
- SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights
- Semaglutide May Induce Weight Loss in Type 2 Diabetes Despite BMI
- FDA Clears Omnipod DASH System for Diabetes Management
- IV Fluid Infusion Rates Do Not Affect Pediatric DKA Neurologic Outcomes
- Effect of Fructose, Allulose on Postprandial Glucose Regulation in Type 2 Diabetes
- Psychiatric Morbidity Decreased After Assisted Reproductive Technology Treatment
- Fenofibrate Improves Cholesterol Levels in Type 2 Diabetes
- Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk